Enhancing cellular uptake of activable cell-penetrating peptide–doxorubicin conjugate by enzymatic cleavage

References

• FawellSSeeryJDaikhYTat-mediated delivery of heterologous proteins into cellsProc Natl Acad Sci U S A19949126646688290579
   PubMed Web of Science ®Google Scholar
• ChiuYLAliAChuCYCaoHRanaTMVisualizing a correlation between siRNA localization, cellular uptake, and RNAi in living cellsChem Biol20041181165117515324818
   PubMed Web of Science ®Google Scholar
• RothbardJBGarlingtonSLinQConjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammationNat Med20006111253125711062537
   PubMed Web of Science ®Google Scholar
• SantraSYangHStanleyJTRapid and effective labeling of brain tissue using TAT-conjugated CdS:Mn/ZnS quantum dotsChem Commun (Camb)20057253144314615968352
   PubMed Web of Science ®Google Scholar
• LewinMCarlessoNTungCHTat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cellsNat Biotechnol200018441041410748521
   PubMed Web of Science ®Google Scholar
• MazelMClairPRousselleCDoxorubicin-peptide conjugates overcome multidrug resistanceAnticancer Drugs200112210711611261883
   PubMed Web of Science ®Google Scholar
• LiangJFYangVCSynthesis of doxorubicin-peptide conjugate with multidrug resistant tumor cell killing activityBioorg Med Chem Lett200515225071507516168650
   PubMed Web of Science ®Google Scholar
• ArouiSBrahimSDe WaardMBréardJKenaniAEfficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231Cancer Lett20092851283819523755
   PubMed Web of Science ®Google Scholar
• ArouiSBrahimSHamelinJDe WaardMBréardJKenaniAConjugation of doxorubicin to cell penetrating peptides sensitizes human breast MDA-MB 231 cancer cells to endogenous TRAIL-induced apoptosisApoptosis200914111352136519731037
   PubMed Web of Science ®Google Scholar
• LindgrenMRosenthal-AizmanKSaarKOvercoming methotrexate resistance in breast cancer tumour cells by the use of a new cell-penetrating peptideBiochem Pharmacol200671441642516376307
   PubMed Web of Science ®Google Scholar
• ArouiSBrahimSWaardMDKenaniACytotoxicity, intracellular distribution and uptake of doxorubicin and doxorubicin coupled to cell-penetrating peptides in different cell lines: a comparative studyBiochem Biophys Res Commun2010391141942519914216
   PubMed Web of Science ®Google Scholar
• MaDXShiNQQiXRDistinct transduction modes of arginine-rich cell-penetrating peptides for cargo delivery into tumor cellsInt J Pharm20114191–220020821843610
   PubMed Web of Science ®Google Scholar
• VivèsESchmidtJPèlegrinACell-penetrating and cell-targeting peptides in drug deliveryBiochim Biophys Acta20081786212613818440319
   PubMed Web of Science ®Google Scholar
• FonsecaSBPereiraMPKelleySORecent advances in the use of cell-penetrating peptides for medical and biological applicationsAdv Drug Deliv Rev2009611195396419538995
   PubMed Web of Science ®Google Scholar
• LawBTungCHProteolysis: a biological process adapted in drug delivery, therapy, and imagingBioconjug Chem20092091683169519754162
   PubMed Web of Science ®Google Scholar
• JiangTOlsonESNguyenQTRoyMJenningsPATsienRYTumor imaging by means of proteolytic activation of cell-penetrating peptidesProc Natl Acad Sci U S A200410151178671787215601762
   PubMed Web of Science ®Google Scholar
• AguileraTAOlsonESTimmersMMJiangTTsienRYSystemic in vivo distribution of activatable cell penetrating peptides is superior to that of cell penetrating peptidesIntegr Biol (Camb)200915–637138120023744
   PubMed Web of Science ®Google Scholar
• OlsonESAguileraTAJiangTIn vivo characterization of activatable cell penetrating peptides for targeting protease activity in cancerIntegr Biol (Camb)200915–638239320023745
   PubMed Web of Science ®Google Scholar
• OlsonESJiangTAguileraTAActivatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteasesProc Natl Acad Sci U S A201010794311431620160077
   PubMed Web of Science ®Google Scholar
• NguyenQTOlsonESAguileraTASurgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survivalProc Natl Acad Sci U S A201010794317432220160097
   PubMed Web of Science ®Google Scholar
• GiambernardiTAGrantGMTaylorGPOverview of matrix metalloproteinase expression in cultured human cellsMatrix Biol19981684834969550265
   PubMed Web of Science ®Google Scholar
• DasSBanerjiAFreiEChatterjeeARapid expression and activation of MMP-2 and MMP-9 upon exposure of human breast cancer cells (MCF-7) to fibronectin in serum free mediumLife Sci2008829–1046747618243246
   PubMed Web of Science ®Google Scholar
• AlbrightCFGracianiNHanWMatrix metalloproteinase-activated doxorubicin prodrugs inhibit HT1080 xenograft growth better than doxorubicin with less toxicityMol Cancer Ther20054575176015897239
   PubMed Web of Science ®Google Scholar
• TianQZhangCNWangXHGlycyrrhetinic acid-modified chitosan/poly(ethylene glycol) nanoparticles for liver-targeted deliveryBiomaterials201031174748475620303163
   PubMed Web of Science ®Google Scholar
• MurphyGNagaseHProgressin matrix metalloproteinase researchMol Aspects Med2008295290308
   Google Scholar
• WenderPAMitchellDJPattabiramanKPelkeyETSteinmanLRothbardJBThe design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transportersProc Natl Acad Sci U S A20009724130031300811087855
   PubMed Web of Science ®Google Scholar
• KlineTTorgovMYMendelsohnBACervenyCGSenterPDNovel antitumor prodrugs designed for activation by matrix metalloproteinases- 2 and -9Mol Pharm20041192215832497
   PubMed Web of Science ®Google Scholar
• SmithRSewellSLGiorgioTDProximity-activated nanoparticles: in vitro performance of specific structural modification by enzymatic cleavageInt J Nanomedicine2008319510318488420
   PubMed Web of Science ®Google Scholar
• WangPCQiXRThe design and enzymatic hydrolysis of activatable cell-penetrating peptideYao Xue Xue Bao20104581048105121351594
   PubMedGoogle Scholar
• SunYYanXYuanTDisassemblable micelles based on reduction-degradable amphiphilic graft copolymers for intracellular delivery of doxorubicinBiomaterials201031277124713120580429
   PubMed Web of Science ®Google Scholar
• LiYLZhuLLiuZReversibly stabilized multifunctional dextran nanoparticles efficiently deliver doxorubicin into the nuclei of cancer cellsAngew Chem Int Ed Engl200948529914991819937876
   PubMed Web of Science ®Google Scholar
• TeradaTIwaiMKawakamiSYamashitaFHashidaMNovel PEG-matrix metalloproteinase-2 cleavable peptide-lipid containing galactosylated liposomes for hepatocellular carcinoma-selective targetingJ Control Release2006111333334216488046
   PubMed Web of Science ®Google Scholar
• NeumannUKubotaHFreiKGanuVLeppertDCharacterization of Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2, a fluorogenic substrate with increased specificity constants for collagenases and tumor necrosis factor converting enzymeAnal Biochem2004328216617315113693
   PubMed Web of Science ®Google Scholar
• LiuSNetzel-ArnettSBirkedal-HansenHLepplaSHTumor cell-selective cytotoxicity of matrix metalloproteinase-activated anthrax toxinCancer Res200060216061606711085528
   PubMed Web of Science ®Google Scholar
• BullokKEDyszlewskiMPriorJLPicaCMSharmaVPiwnica-WormsDCharacterization of novel histidine-tagged Tat-peptide complexes dual-labeled with (99 m)Tc-tricarbonyl and fluorescein for scintigraphy and fluorescence microscopyBioconjug Chem20021361226123712440857
   PubMed Web of Science ®Google Scholar
• RobbinsPBOliverSFSheuSMGoodnoughJBWenderPKhavariPAPeptide delivery to tissues via reversibly linked protein transduction sequencesBiotechniques200233119019219412139245
   PubMed Web of Science ®Google Scholar
• TorchilinVPLevchenkoTSTAT-liposomes: a novel intracellular drug carrierCurr Protein Pept Sci20034213314012678852
   PubMed Web of Science ®Google Scholar
• DubikovskayaEAThorneSHPillowTHContagCHWenderPAOvercoming multidrug resistance of small-molecule therapeutics through conjugation with releasable octaarginine transportersProc Natl Acad Sci U S A200810534121281213318713866
   PubMed Web of Science ®Google Scholar